Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma

BACKGROUND: Limited effective intervention for advanced hepatocellular carcinoma (HCC) is available. This study aimed to investigate the potential clinical utility of apatinib, a highly selective inhibitor of the vascular endothelial growth factor receptor-2 (VEGFR2) tyrosine kinase, as a radiosensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Junbin, Jin, Huilin, Li, Shaoqiang, Xu, Lixia, Peng, Zhenwei, Wei, Guangyan, Long, Jianting, Guo, Yu, Kuang, Ming, Zhou, Qi, Peng, Sui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836669/
https://www.ncbi.nlm.nih.gov/pubmed/31694662
http://dx.doi.org/10.1186/s13046-019-1419-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836669/
https://www.ncbi.nlm.nih.gov/pubmed/31694662
http://dx.doi.org/10.1186/s13046-019-1419-1

Ejemplares similares